Identification and referral for victims and perpetrators of domestic violence Not Applicable
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Inclusion criteria for HCPs (health care professionals) in the PIM+ survey: All HCPs working at or geographically linked with the pilot clinical settings will be invited to complete the REPROVIDE PIM+ survey before and after attending the IRIS+ training intervention 2. Inclusion criteria for HCPs in the IRIS+ clinician interview study: All HCPs in the pilot clinical settings who attended at least one session of the IRIS+ training will be invited to take part in a semi-structured interview. Only those who agree will be contacted further 3. Inclusion criteria in the REPROVIDE survey and interview study for adult IRIS+ client participants: All adult patients (> 16 years of age) who are using or/and experiencing violence/abuse in their relationship to partner(s) or ex-partner(s) and were referred to the IRIS+ service/hub by IRIS+ trained professional as a result will be invited to participate in the REPROVIDE survey and/or interview study. Only those who agree will be contacted further 4. Inclusion criteria in the interview study for IRIS+ child and young people client participants: All children and young people between the ages of 8-18 who and/or whose parents have been referred to the IRIS+ service/hub by HCPs as a result of abuse/violence taking place in the home, who have been in direct contact with the IRIS+ children’s worker, whose non perpetrating (safe) parent/carer agrees for the child to take part and who consents in their own right is eligible to take part Young people aged 16-18 who and/or whose parents have been referred to the IRIS+ service/hub by HCPs as a result of abuse/violence taking place in the home, who have been in direct contact with the IRIS+ children’s worker Young people aged 16-18 also may be referred due to their own intimate relationships and, in this case, would be treated as adults under the IRIS+ protocol. 5. Inclusion criteria for secondary data: With regards to the reviews of patient medical and referral data and IRIS+ client contact and referral data, the records of all patients/clients within relevant pilot practices/agency will be searched and the number of records containing identifications and referrals counted in the pilot sites for the 10 months period post-intervention (between post-delivery of first IRIS+ training intervention for HCPs and the end of feasibility phase
Exclusion criteria
Exclusion criteria: 1. Exclusion criteria for HCPs (health care professionals) in the PIM+ survey: Primary health care professionals not based at or geographically linked with the pilot clinical site (general practice) will be excluded 2. Exclusion criteria for HCPs in the IRIS+ clinician interview study: HCPs in the pilot sites who did not attend at least one training session will be excluded 3. Exclusion criteria in the REPROVIDE survey and interview study for adult IRIS+ client participants: 3.1. IRIS+ clients who are deemed by the researcher to be put at greater risk if they take part in the study 3.2. IRIS+ clients who are deemed by the researcher to be high risk perpetrators of DVA 3.3. IRIS+ clients who cannot understand the English language sufficiently well to give informed consent and to complete the questionnaires 3.4. IRIS+ clients with a diagnosis of a mental illness that will prevent them from research engagement, e.g. active psychosis 3.5. IRIS+ clients who are incapacitated by substance abuse or serious mental illness at time of seeking consent 4. Exclusion criteria for the interview study for IRIS+ child and young people client participants: 4.1. Only safe (non-perpetrating) parent/carers will be asked for consent for their child to take part in research. If the advocate educator is in doubt as to whether the parent/carer is a perpetrator or not, then the child would not be eligible for participation. This is in order to prevent any increased control, manipulation or violence that the perpetrating parent/carer may use to influence or coerce the child in relation to the interview 4.2. The parent/carer or researcher believe that a child or young person’s involvement in the research is likely to cause significant distress or upset 4.3. The parent/carer or researcher believe that a child or young person’s involvement in the research is likely to increase the risk of domestic violence or abuse, or any form of child abuse or neglect within the household 4.4. There are child or adult safeguarding concerns that may compromise the safety of the child or adult participants 4.5. The parent/carer or researcher believe that the child/young person does not have the capacity to understand or consent to the research process
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Professionals’ engagement with and experience of the IRIS+ training and support intervention measured using pre/post-training/intervention questionnaire at baseline and follow-up, and interviews at follow-up 2. IRIS+ patients’ engagement with and experience of the IRIS+ support intervention measured using pre/post-training/intervention questionnaire at baseline and follow-up 3. Number of patient identifications, referrals and contacts (practice and agency data) 4. IRIS+ patients/HCPs’ engagement with research, the value of information and completeness of data measured using pre/post-training/intervention questionnaire at baseline and follow-up, and interviews at follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Primary health professionals’ perception of changes in knowledge, skills, self-efficacy and preparedness to respond to domestic violence and abuse (DVA) measured usinpre/post-training/intervention questionnaire at baseline and follow-up, and interviews at follow-up 2. IRIS+ patients’ and their children’s experiences of DVA and physical and mental health and wellbeing measured using/post-intervention questionnaire at baseline and follow-up and interviews at baseline and follow-up for adults and follow-up only for children 3. Cost-effectiveness of the reconfigured IRIS+ model and value of information measured using pre/post-intervention questionnaire at baseline and follow-up | — |
Countries
England, United Kingdom, Wales